Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Segawa

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapyY Segawa, K Aogi, K Inoue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2009
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyM Maemondo, N Masuda, I Sekine, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1993
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines]N Takigawa, T Ohnoshi, H Ueoka, et al.
Acta Medica Okayama|June 1, 1993
Immunohistochemical detection of P-glycoprotein and carcinoembryonic antigen in small cell lung cancer: with reference to predictability of response to chemotherapyY Segawa, T Ohnoshi, S Hiraki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicityN Takigawa, Y Segawa, T Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1995
[Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)]T Shibayama, J Hiyama, H Ueoka, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|June 1, 1992
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]T Shibayama, T Ohnoshi, H Ueoka, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1992
[Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy]T Ohnoshi, H Ueoka, N Hino, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|November 1, 1991
[Double cancer in small cell lung cancer patients treated with intensive chemotherapy with or without radiation therapy]Y Segawa, T Ohnoshi, H Ueoka, et al.
Transplantation Proceedings|November 3, 2004
Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injuryR Yoshimura, M Matsuyama, Y Segawa, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapyY Segawa, K Aogi, K Inoue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2009
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapyM Maemondo, N Masuda, I Sekine, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1993
[In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines]N Takigawa, T Ohnoshi, H Ueoka, et al.
Acta Medica Okayama|June 1, 1993
Immunohistochemical detection of P-glycoprotein and carcinoembryonic antigen in small cell lung cancer: with reference to predictability of response to chemotherapyY Segawa, T Ohnoshi, S Hiraki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2000
Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicityN Takigawa, Y Segawa, T Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1995
[Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)]T Shibayama, J Hiyama, H Ueoka, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|June 1, 1992
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer]T Shibayama, T Ohnoshi, H Ueoka, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1992
[Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy]T Ohnoshi, H Ueoka, N Hino, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|November 1, 1991
[Double cancer in small cell lung cancer patients treated with intensive chemotherapy with or without radiation therapy]Y Segawa, T Ohnoshi, H Ueoka, et al.
Transplantation Proceedings|November 3, 2004
Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injuryR Yoshimura, M Matsuyama, Y Segawa, et al.
Pageof 17